Template:Nitric oxide signaling modulators
From WikiMD's WELLNESSPEDIA
| Nitric oxide signaling modulators |
| Forms | |
| Targets | |
NO donors
(prodrugs) | |
Enzyme
(inhibitors) | |
| Others | * Precursors: L-Arginine
- Indirect/downstream NO modulators: ACE inhibitors/AT-II receptor antagonists (e.g., captopril, losartan)
- ETB receptor antagonists (e.g., bosentan)
- L-Type calcium channel blockers (e.g., dihydropyridines: nifedipine)
- Nebivolol (beta blocker)
- PDE5 inhibitors (e.g., sildenafil)
- non-selective PDE inhibitors (e.g., caffeine)
- PDE9 inhibitors (e.g., paraxanthine)
- cGMP preferring PDE inhibitors (e.g., sildenafil, paraxanthine, tadalafil)
- Statins (e.g., simvastatin)
|
|
